The drug is used to treat osteoporosis in postmenopausal women at high risk of a fracture or who have not responded to similar therapies.
Tymlos, an intravenous drug, carries a box warning over the risk of bone cancer.
More articles on supply chain:
FDA approves RFID device to locate breast lumps
9 strategies to lower drug costs, as ranked by public support
Poll: GOP prioritizes lower drug prices over reducing government’s role in healthcare
